(Q36634631)

15 August 2017

1 reference

title

Uric Acid and renal disease (English)

1 reference

15 August 2017

J Stewart Cameron

1

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Nucleosides, Nucleotides & Nucleic Acids

15 August 2017

published in

1 reference

15 August 2017

volume

25

1 reference

15 August 2017

issue

9-11

1 reference

15 August 2017

page(s)

1055-1064

1 reference

Hereditary hyperuricemia and renal disease

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

The multispecific organic anion transporter (OAT) family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Galectin 9 is the sugar-regulated urate transporter/channel UAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Studies on the pathophysiology of the low urine pH in patients with uric acid stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Pathophysiologic basis for normouricosuric uric acid nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Uric acid nephropathy and end-stage renal disease--review of a non-disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Infections in 92 splenectomized patients with Hodgkin's disease. A clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Renal impairment and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Tumor lysis syndrome: pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

An evaluation of the pathogenesis of the gouty kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Management of hyperuricemia with rasburicase review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Urate oxidase (rasburicase) for treatment of severe tophaceous gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Uric acid as a risk factor for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Effect of insulin on renal sodium and uric acid handling in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

A role for uric acid in the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Renal outcomes of gout and hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Allopurinol treatment and its effect on renal function in gout: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770600890954

10.1080/15257770600890954

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference